Metagenomi

Biotechnology company based in Emeryville, California, focused on discovering breakthrough gene editing systems for curing genetic diseases. Founded in 2018 by metagenomics researchers from UC Berkeley, the company uses metagenomics to unlock microbial evolution and identify novel nucleases with unique gene editing capabilities. Metagenomi aims to develop innovative in vivo and ex vivo therapeutics to transform the landscape of cell and gene therapies, primarily targeting patients with genetic disorders.